Life Science Company News

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

Read more ››
By: GlobeNewswire - 02 May 2024

BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

Read more ››
By: GlobeNewswire - 02 May 2024

Guangzhou Bio-gene Technologies Announces Initiation of Phase I Clinical Trial for BG1805, a CAR-T Targeting CLL-1

Read more ››
By: GlobeNewswire - 02 May 2024

Context Therapeutics Announces $100 Million Private Placement

Read more ››
By: GlobeNewswire - 02 May 2024

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 02 May 2024

Quipt Home Medical Announces Normal Course Issuer Bid

Read more ››
By: GlobeNewswire - 02 May 2024

VitalHub Announces Q1 2024 Conference Call Date

Read more ››
By: GlobeNewswire - 02 May 2024

Biogen Reports Progress on Corporate Responsibility Priorities

Read more ››
By: GlobeNewswire - 02 May 2024

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

Read more ››
By: GlobeNewswire - 02 May 2024

Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates

Read more ››
By: GlobeNewswire - 02 May 2024

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

Read more ››
By: GlobeNewswire - 02 May 2024

Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76

Read more ››
By: GlobeNewswire - 02 May 2024

BioPorto A/S to Host First Quarter 2024 Earnings Webcast and Investor Meeting

Read more ››
By: GlobeNewswire - 02 May 2024

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Read more ››
By: GlobeNewswire - 02 May 2024

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Read more ››
By: GlobeNewswire - 02 May 2024

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

Read more ››
By: GlobeNewswire - 02 May 2024

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Read more ››
By: GlobeNewswire - 02 May 2024

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

Read more ››
By: GlobeNewswire - 02 May 2024

NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate